These Penny Stocks Made Big Moves, Premarket; Are They Heading Higher?
In true, volatile fashion the stock market flipped in the other direction this morning. While this type of volatility is typical of a bearish market, it hasn’t stopped countless penny stocks from heading higher. This week we’re looking for the U.S. government to make a decision on the coronavirus stimulus plan. While this, in itself could be a catalyst for the market, what is reported after will be something to take note of.
Tuesday we’re seeing big moves in gold, biotech, and a few ancillary niches making new highs right now. If you’re actively trading penny stocks, you already know that this volatility can be a curse and a blessing. On top of that, it’s also important to take profit while penny stocks are on the rise. A good rule of thumb is that if trading is wild and you don’t know exactly what to do, watching the market for a few minutes may be your best bet.
I’m talking about volatility so much today because the market is whipsawing a lot lately. In many cases, your investment thesis could be correct. But the market may flip in the opposite direction simply based on emotional trading. Headline risk becomes a key component here. That “risk” could also become a reward. Higher prices are seen with a number of penny stocks mentioning progress with coronavirus vaccines & related news.
Additionally, as I said above, gold stocks could be set to benefit from all of the fiscal policy being thrown around right now. At the end of the day, you want to look for good trade set-ups in order to make money with penny stocks. With this in mind, here’s a short list of penny stocks to watch on Tuesday morning.
Penny Stocks To Trade [or fade]: Akers Biosciences Inc.
Akers Biosciences (AKER Stock Report) was relatively quiet for most of this year. But like I said above, the coronavirus has created a whole new opportunity for certain biotech penny stocks. On March 24 the company made a big announcement.
Akers reported the acquisition of a licensing agreement with Premas Biotech where Akers will in-license a coronavirus vaccine candidate. While shares of AKER stock gapped up during premarket hours, it seems like things may have settled down during the morning session. Considering the base case for coronavirus penny stocks, these can become incredibly volatile. Earlier on during the initial days of the pandemic in January, we started talking about this idea of COVID19 stocks. Since that time, we’ve seen many breakout big. Whether or not that could be the case for Akers is yet to be seen.
Prabuddha Kundu, Co-Founder and Managing Director at Premas Biotech, added, “The strategic relationship today between Premas and Akers should accelerate our development timeline as we leverage the proven D-CryptTm platform and Akers’ 30 years of operational experience navigating the healthcare regulatory environment. We believe our platform has three key advantages which we believe will set our potential vaccine apart in the industry.”
Penny Stocks To Trade [or fade]: Aytu BioScience
One of the penny stocks we’ve discussed for a few weeks now has been Aytu BioScience (AYTU Stock Report). Earlier this week the company reported that it received the OK from the FDA to distribute a COVID-19 rapid test in the U.S. Obviously with so much attention on preventative measures, testing has become a key proponent for healthcare networks. The “stay home” measures are one thing but know who or if carriers of the virus are receiving proper treatment starts with testing.
The company expects delivery of the first 100,000 tests this week. Aytu has also been in discussions with healthcare distributors and institutions to begin rolling out the test in the U.S. supply chain. While this is great news for the company, it’s also important to monitor the trend of AYTU stock if it’s on your list of penny stocks right now. Shares have extended gains in a big way for the last 3 trading days. In many cases, some could assume a profit-taking situation.
Case in point, AYTU stock has climbed 72% with surging volume since last Friday. So here’s my 2 cents: we don’t write these articles to talk about all the great things penny stocks have to offer. While it’s great to be optimistic about certain names, it’s also important to report on potential risks. AYTU is a popular penny stock right now and likely on many watch lists based on the daily volume. If it’s on your list of penny stocks, be in tune with the fact that it’s had a hard time staying above $2 all year. Sure, it broke above it a few days. But for the most part, AYTU has pulled back each time it traded above $2. Keep this in mind if it’s one of the penny stocks you watching this week.
Penny Stocks To Trade [or fade]: Capricor Therapeutics
Finally, Capricor Therapeutics (CAPR Stock Report) saw a spike on Tuesday. Shares broke and traded above its 50-day moving average for the first time since early February. Keep in mind that the last big volume day CAPR stock had was earlier this month when it traded more than 1.5 million shares. As of about 10AM EST, it has already traded more than 1.2 million.
Why did Capricor stock rally? During the March 24 premarket session, Capricor reported that it will host a Key Opinion Leader call on Thursday. The topic of conversation will cover why exomes are suited for vaccine development. Capricor’s Executive Consultant, Stephen Gould, Ph.D. will discuss the plan to further develop the company’s platform technologies. In line with this, Gould will talk specifics about the potential application of the platform as a COVID-19 vaccine.
Once again, we see headlines help push momentum for certain stocks. Capricor has become the latest company to become one of the coronavirus penny stocks to watch. Depending on the outcome of the call, there may or may not be more topics of discussion when it comes to this company. So if CAPR is on your list of penny stocks, March 26 will be an important date to keep in mind.